Plasma testosterone content of male patients with Parkinson's disease during L-dopa treatment with or without dopadecarboxylase inhibitor.
作者信息
Pekkarinen A, Rinne U K, Salokangas R, Siirtola T, Sonninen V
出版信息
Acta Neurol Scand Suppl. 1972;51:129-30.
PMID:4514339
Abstract
摘要
相似文献
1
2
Treatment of Parkinsonism with a compound of L-dopa (Larodopa R) and a decarboxylase inhibitor (RO-46-4602).使用左旋多巴（美多巴R）和一种脱羧酶抑制剂（RO-46-4602）的化合物治疗帕金森症。
Acta Neurol Scand Suppl. 1972;51:121-2.
3
Treatment of Parkinsonism with L-dopa and decarboxylase inhibitors. An electrophysiological study.左旋多巴和脱羧酶抑制剂治疗帕金森病。一项电生理研究。
Acta Neurol Scand Suppl. 1972;51:111-3.
4
[Treatment of Parkinson's disease with L-dopa alone or combined with Ro 4-4602].
Rev Can Biol. 1972;31:Suppl:169-74.
5
[Drug therapy of Parkinson's syndrome. Clinical long-term study using L-dopa and the drug conbination L-dopa-decarboxylase inhibitor].
Munch Med Wochenschr. 1973 Apr 20;115(16):711-3.
6
7
Dopa-decarboxylase inhibitors.多巴脱羧酶抑制剂
Lancet. 1973 May 5;1(7810):979-80.
8
Treatment of Parkinson's disease with levodopa combined with L-alpha-methyldopahydrazine, an inhibitor of extracerebral DOPA decarboxylase.左旋多巴联合脑外多巴脱羧酶抑制剂L-α-甲基多巴肼治疗帕金森病。
J Neurol Neurosurg Psychiatry. 1973 Feb;36(1):10-4. doi: 10.1136/jnnp.36.1.10.
9
[Treatment of Parkinson's syndrome with L-dopa and a decarboxylase inhibitor].左旋多巴与脱羧酶抑制剂治疗帕金森综合征
Arch Invest Med (Mex). 1974;5(2):105-16.
10
[Treatment of parkinsonism with L-dopa and an L-aromatic amino acid inhibitor].
Harefuah. 1972 Nov 1;83(9):362-4.
引用本文的文献
1
Understanding the dopaminergic pathway relative to men's sexual dysfunction in patients with Parkinson's disease: a narrative review with implications for future research.了解帕金森病患者中与男性性功能障碍相关的多巴胺能通路：一项对未来研究有启示的叙述性综述
Int J Impot Res. 2024 May;36(3):181-185. doi: 10.1038/s41443-022-00656-3. Epub 2022 Dec 26.
Zotero 插件